An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2

An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2
复制标题

DOI:
10.1097/mbp.0000000000000086
复制
发表时间:
2015-02-01
影响因子:
1.3
通讯作者:
Shennan, Andrew H.
Shennan, Andrew H.
中科院分区:
医学4区
文献类型:
--
作者:
Nathan, Hannah L.;de Greeff, Annemarie;Shennan, Andrew H.

文献摘要

被引文献

相似文献

目的 评估 Microlife 3AS1-2 血压装置在资源匮乏的环境中治疗妊娠和先兆子痫的准确性。方法 根据英国高血压协会协议进行前瞻性验证。从金伯利医院(南非)总共招募了 45 名孕妇,其中 15 名患有先兆子痫。结果 Microlife 3AS1-2 设备在妊娠期(包括先兆子痫)总体达到 B/A 级,通过了英国高血压协会协议要求并达到国际标准化组织标准,收缩压和收缩压的平均差和 SD 分别为 -3.8 +/- 7.3 和 -1.5 +/- 6.2 mmHg。结论 Microlife 3AS1-2 装置推荐用于妊娠期,包括先兆子痫。此外,它还满足世界卫生组织对适合在资源匮乏环境中使用的自动血压装置的要求。这使其成为低收入和中等收入国家产前诊所和初级医疗保健机构的理想设备。版权所有 (C) 2015 Wolters Kluwer Health, Inc. 保留所有权利。
Objectives To assess the accuracy of the Microlife 3AS1-2 blood pressure device in pregnancy and pre-eclampsia in a low-resource setting.Methods Prospective validation according to the British Hypertension Society protocol. A total of 45 pregnant women were recruited from Kimberley Hospital (South Africa), of whom 15 had pre-eclampsia.Results The Microlife 3AS1-2 device achieved an overall B/A grade in pregnancy (including pre-eclampsia), passing the British Hypertension Society protocol requirements and achieving the International Organization for Standardization standard with a mean difference and SD of -3.8 +/- 7.3 and -1.5 +/- 6.2 mmHg for systolic and diastolic pressures, respectively.Conclusion The Microlife 3AS1-2 device can be recommended for use in pregnancy, including pre-eclampsia. In addition, it fulfils the requirements stipulated by the WHO for an automated blood pressure device suitable for use in a low-resource setting. This makes it the ideal device for antenatal clinics and primary healthcare facilities in low-income and middle-income countries. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.